.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Jade Nectar is stocked at 22 licensed dispensaries across California, with the deepest coverage in San Jose, Santa Rosa, Soquel, Antioch, and Boulder Creek. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Jade Nectar remained overwhelmingly concentrated in Tincture & Sublingual during September 2026, with a 99.03% category share and an 11th-place rank in California, while the much smaller Topical segment held 0.97% share. Year over year, Tincture & Sublingual declined 41.96% and month over month fell 19.45%, whereas Topical contracted 47.72% YoY but grew 36.63% MoM off a small base. With overall brand sales down 42.02% YoY and average price essentially flat at +0.92% YoY, the pattern implies concentration risk: the single-category reliance amplified the YoY drop, and the rank at 11 suggests limited headroom unless mix broadens or Tincture & Sublingual velocity improves.
The mix shift signals that Jade Nectar’s positioning is tied to Tincture & Sublingual price and velocity rather than portfolio diversification, given 99.03% share in that category and a concurrent 19.45% MoM step-down in September 2026. The small but rising Topical MoM of 36.63% offers a testable adjacency, yet its 0.97% share and 47.72% YoY decline indicate it cannot offset a 41.96% YoY slump in the core. The implication is a need to defend rank 11 in California Tincture & Sublingual via retention and repeat, while using targeted Topical experiments to build a second leg without diluting focus.
Competitive Landscape
Jade Nectar sits at rank #11 in California Tincture & Sublingual for September 2026, down 3 positions year over year from #8 and 1 position lower than June 2026’s #10, while still trailing its peak of #7 from September 2024; in contrast, Papa & Barkley held #1 both this year and last despite a -8.4% YoY sales change, and Mary's Medicinals advanced from #7 to #5 on +22.3% YoY sales. Compared with Yummi Karma steady at #2 with +7.8% YoY and Care By Design flat at #3 despite a -23.9% YoY decline, Jade Nectar’s 3-position YoY rank erosion alongside a 1-position QoQ slip signals share leakage toward stable top incumbents and upwardly mobile mid-pack players, implying that without a near-term catalyst the brand is more likely to oscillate outside the top 10 than to regain its prior #7 peak.
Notable Products
The steepest movement in September 2026 came from CBD:THC 1:1 Balance Tincture (150mg CBD, 150mg THC, 30ml), which surged 546.7% month over month into rank 8, while Sativa Tincture Drops (1000mg THC, 30ml) fell 46.4% to rank 4. The top two positions held steady for CBD/THC 30:1 CBD Drops (900mg CBD, 30mg THC, 30ml) at rank 1 with a 3.7% decline and Indica Sativa High Potency Blend Tincture (1000mg THC, 30ml) at rank 2 with a 16.2% gain. Eight of the top ten are Tincture & Sublingual SKUs, and the mix shows sharp divergence between 1:1 and high-THC lines, implying Jade Nectar is pivoting toward balanced formulations to stabilize volume against volatility in single-cannabinoid tinctures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
